Drugs / SJ-Neo006
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT06326736 | Apr 2024 → Dec 2025 overdue | malignant pancreatic neoplasm | Jinling Hospital, China | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SJ-Neo006 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06326736 ↗ |
| Modality | Messenger RNA (mRNA) | “Neoantigen mRNA Vaccines” NCT06326736 ↗ |